The 9 Work Packages (WP)



    Identification of PRECLINICAL immune gene signatures before and after surgery and during adjuvant immunotherapy
    Map out specific gene signatures to predict for disease progression in HUMANS and utilising this as the basis to formulating different immunomodulation strategies

    Development and testing of preclinical models and biodegradable materials for immunotherapy

    Postoperative (adjuvant) biomaterial-based delivery of therapeutics and subsequent outcome studies in mice

    Combination adjuvant immunotherapy in canines of the most promising combinations from WP4
    Quality control
    Communication and Dissemination